Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2007.092 | A Randomized Placebo Controlled Trial of Vitamin B12 Supplementation to Prevent Cognitive Decline in Older Women with Vitamin B12 Deficiency | Prof. Kwok Timothy |
| 2001.429 | A Randomized Placebo Controlled Trial of Traditional Chinese Medicine in the Treatment of Irritable Bowel Syndrome | Prof. Leung Wai Keung |
| 2009.183 | A randomized placebo controlled trial of low dose angiotensin converting enzyme inhibitor to prevent pneumonia in older people who require tube feeding because of neurological dysphagia | Prof Kwok Timothy |
| 2011.207 | A randomized placebo controlled trial of homocysteine lowering to prevent dementia in older patients with mild cognitive impairment and high plasma homocysteine | Prof Kwok Timothy |
| 2008.342 | A Randomized Placebo Controlled Trial of Alternative Herbal Medicine (Danshen/Gegen) in the Prevention of Atherosclerosis in Postmenopausal Women with Hypercholesterolemia | Prof. Kwok Timothy |
| 2009.386 | A randomized phase III, double-blind, placebo-controlled multicenter trial of Everolimus in combination with Trastuzumab and Paclitaxel, as first line therapy in women with HER2 positive locally advanced or metastatic breast cancer | Dr. HO Wing Ming |
| 2010.564 | A Randomized Phase III study of Oxaliplatin (Eloxatin) and Capecitabine on top of Sorafenib versus Sorafenib alone as first-line palliative treatment in advanced hepatocellular carcinoma patients ineligible for curative resection or local treatment | Prof Chan Lam |
| 2004.179 | A Randomized Phase II Study to Investigate the Effects of Recombinant Intestinal Trefoil Factor (ITF) on Oral Mucositis in Nasopharyngeal Cancer (NPC) Patients Receiving Radiation Therapy | Prof. Leung Sing Fai |
| 2004.031 | A Randomized Phase II Study to Evaluate the Effect of CKBM-T01 Vs Tamoxifen on Quality of Life (QOL) of Patients with Inoperable Hepatocellular Carcinoma (HCC) | Prof. Mok Tony |
| 2002.050 | A Randomized Phase II Study of Concurrent Cisplatin-Radiotherapy With or Without Neoadjuvant Chemotherapy Using Taxotere and Cisplatin in Advanced Nasopharyngeal Carcinoma | Prof. Chan Tak Cheung Anthony |
| 2009.248 | A randomized phase II study comparing acupuncture to acupuncture with moxibustion on reduction of chemotherapy-induced neutropenia | Professor Mok Tony |
| 2008.479 | A Randomized Phase I/II, Multi-Center, Open-Label Trial of PR104 and Sorafenib in Patients with Advanced Hepatocellular Carcinoma | Dr. Chan Stephen Lam |
| 2010.602 | A Randomized Phase 4 Study Comparing 2 Intravenous Temsirolimus (TEMSR) Regimens in Subjects With Relapsed, Refractory Mantle Cell Lymphoma | Dr. LEI Kenny Ieng Kit |
| 2021.631 | A Randomized Phase 3 Study of MRTX849 versus Docetaxel in Patients with Previously Treated Non-Small Cell Lung Cancer with KRAS G12C Mutation |
Prof. MOK Tony Shu Kam 莫樹錦 |
| 2022.654 | A Randomized Phase 3 Study of Datopotamab Deruxtecan (Dato-DXd) and Pembrolizumab, with or Without Platinum Chemotherapy, in Subjects with No Prior Therapy for Advanced or Metastatic PD-L1 TPS <50% Non-squamous Non-small Cell Lung Cancer Without Actionable Genomic Alterations (TROPION-Lung07) | Dr. LOONG Herbert Ho Fung |
| 2011.179 | A Randomized Phase 3 Study Comparing First-Line Pemetrexed plus Cisplatin (Followed by Gefitinib as Maintenance) with Gefitinib Monotherapy in East Asian (Never Smoker or Light Ex-Smoker) Patients with Locally Advanced or Metastatic Nonsquamous Non-Small Cell Lung Cancer | Prof. Mok Tony Shu Kam |
| 2020.025 | A Randomized Phase 3 Multicenter Open-label Study to Compare the Efficacy of TAK-788 as First-line Treatment Versus Platinum-Based Chemotherapy in Patients With Non–Small Cell Lung Cancer With EGFR Exon 20 Insertion Mutations |
Prof. MOK Tony 莫樹錦教授 |
| 2009.024 | A Randomized Phase 2 Trial of PF-00299804 versus Erlotinib for the Treatment of Advanced Non-Small Cell Lung Cancer after Failure of at Least One Prior Chemotherapy Regimen | Prof. Mok TONY S.K. |
| 2007.471 | A Randomized Phase 2 Trial of Double-Blind, Placebo Controlled AMG 706 in Combination with Paclitaxel, or Open-Label Bevacizumab in Combination with Paclitaxel, as First Line Therapy in Women with HER2 Negative Locally Recurrent or Metastatic Breast Cancer | Dr. HO Wing Ming |
| 2014.404 | A Randomized Phase 2 Study of LY2157299 versus LY2157299 – Sorafenib Combination versus Sorafenib in Patients with Advanced Hepatocellular Carcinoma | Prof. CHAN Stephen Lam |
| 2008.229 | A Randomized Phase 2 Study Comparing Erlotinib-Pemetrexed, Pemetrexed Alone, and Erlotinib Alone, As Second-Line Treatment for Non-Smoker Patients with Locally Advanced or Metastatic Nonsquamous Non-Small Cell Lung Cancer | Professor Mok Tony S. K. |
| 2016.506 | A Randomized Parallel-Group, Placebo-Controlled, Double-Blind, Event-Driven, Multi-Center Pivotal Phase III Clinical Outcome Trial of Efficacy and Safety of the Oral sGC Stimulator Vericiguat in Subjects With Heart Failure With Reduced Ejection Fraction (HFrEF) - VerICiguaT Global Study in Subjects With Heart Failure With Reduced Ejection Fraction (VICTORIA) |
Prof. LEE Alex Pui Wai 李沛威教授 |
| 2012.279 | A randomized parallel group single blinded study of effects of Dayan (Wild Goose) Qigong on type 2 diabetes patients with low cardiovascular risk. | Dr. Tsang Chiu-Chi |
| 2016.551 | A Randomized Open-label Study to Evaluate the Efficacy and Safety of Tacrolimus and Corticosteroids in Comparison with Mycophenolate Mofetil and Corticosteroids in Subjects with Class III/IV±V Lupus Nephritis |
Prof. TAM Lai Shan 譚麗珊 |
| 2015.507 | A Randomized Open-Label Phase III Study of Single Agent Pembrolizumab versus Single Agent Chemotherapy per Physician’s Choice for Metastatic Triple Negative Breast Cancer (mTNBC) – (KEYNOTE-119) |
Prof. YEO Winnie 楊明明 |
| 2021.640 | A Randomized Open-Label Phase III Study of Sacituzumab Govitecan Versus Treatment of Physician’s Choice in Subjects with Metastatic or Locally Advanced Unresectable Urothelial Cancer |
Dr. WONG Kenneth Chun Wai 王俊威 |
| 2023.583 | A Randomized Open-Label Phase 3 Study of XL092 + Nivolumab vs Sunitinib in Subjects with Advanced or Metastatic Non-Clear Cell Renal Cell Carcinoma | Prof. NG Chi Fai |
| 2022.413 | A Randomized Open-Label Phase 3 Study of XL092 + Atezolizumab vs Regorafenib in Subjects with Metastatic Colorectal Cancer |
Prof. MA Brigette Buig Yue 馬碧如 |
| 2021.497 | A Randomized Multicenter Phase 3 Study of Milademetan Versus Trabectedin in Patients with Dedifferentiated Liposarcoma |
Dr. LOONG Herbert Ho Fung 龍浩鋒 |
| 2011.339 | A randomized double-blinded, controlled evaluation of the effectiveness of iv PCA morphine in patients receiving intercostal nerve blocks after video-assisted thoracosopic procedure. Is PCA morphine necessary in addition to intercostals nerve block for Vi | Dr Lam Kit Ying |
| 2020.080 | A randomized double-blind, placebo-controlled, multicenter trial assessing the impact of lipoprotein (a) lowering with TQJ230 on major cardiovascular events in patients with established cardiovascular disease |
Prof. YAN Bryan Ping Yen 甄秉言教授 |
| 2004.035 | A Randomized Double-Blind Placebo-Controlled Trial of Prophylactic Antibiotics in Preventing Female Urinary Tract Infection After Urodynamic Study | Prof. Yip Shing Kai |
| 2004.134 | A Randomized Double-blind Placebo-controlled Study to Assess the Prevention of Low-dose Acetylsalicylic Acid (ASA) Associated Gastroduodenal Lesions and Upper Gastrointestinal Symptoms in Patients Taking Esomeprazole 20 mg Once Daily (od) for 26 Weeks | Prof. Chan Ka Leung Francis |
| 2002.152 | A Randomized Double-Blind Placebo-Controlled Study of The Effect Of Danggui Preparation On Menopausal Symptoms And Quality Of Life In Hong Kong Chinese Women | Prof. Haines Christopher John |
| 2005.418 | A Randomized Double-Blind Phase-2 Study of Anastrozole Plus Lonafarnib (SCH 66336) or Anastrozole Plus Placebo for the Treatment of Subjects With Advanced Breast Cancer | Prof. Yeo Winnie |
| 2004.126 | A Randomized Double-blind Dose-dependent Trial to Assess the Safety and Efficacy of HERBAL FORMULA on Patients with Lung Cancer | Prof. Liew Choong Tsek |
| 2004.127 | A Randomized Double-blind Dose-dependent Trial to Assess the Safety and Efficacy of HERBAL FORMULA on Patients with Colorectal Cancer | Prof. Liew Choong Tsek |
| 2011.396 | A Randomized Double Blind Phase 3 Efficacy And Safety Study Of PF-00299804 Versus Erlotinib For The Treatment Of Advanced Non-Small Cell Lung Cancer Following Progression After, Or Intolerance To, At Least One Prior Chemotherapy | Prof. MOK Tony |
| 2016.725 | A randomized crossover trial to investigate the effects of walnut intervention on blood lipids, inflammatory markers, blood pressure, and adiposity measurements among breast cancer survivors in Hong Kong |
Prof. Su Xuefen 蘇雪芬 |
| 2012.530 | A randomized crossover trial to compare the changes of postprandial oxidative stress after consumption of meals from different cultures in healthy Chinese adults | Prof Chan Suk-mei Ruth |
| 2017.541 | A randomized controlled, single blinded study on the efficacy of a hybrid tilt table and electromechanical gait-training device in lower limb recovery in patients with severe stroke |
Dr. FAN Florence Sin Ying 樊倩英 |
| 2009.535 | A randomized controlled trial: the effect of a targeted secondary prevention program on quality of life and risk factor control in Chinese patients with acute coronary syndrome | Associate Professor Lam Yat Yin |
| 2001.488 | A Randomized Controlled Trial to Investigate the Role of Indocyanine Green-Assited Retinal Limiting Membrane Removal in Primary Idiopathic Macular Hole Surgery | Prof. Kwok Kwan Ho Alvin |
| 2013.094 | A randomized controlled trial to investigate the independent and joint effects of diet and exercise on endogenous estrogen concentrations among overweight/obese postmenopausal Chinese women in Hong Kong | Prof. Su Xuefen |
| 2010.516 | A randomized controlled trial to investigate the impact of sleep education program on glycemic control in Hong Kong Chinese type 2 diabetic patients. | Prof. KONG Alice Pik Shan |
| 2015.358 | A Randomized Controlled Trial to Investigate the Impact of a self-managed Low Glycemic Index Diet program (SLGID) on Outcomes of Metabolic Syndrome Patients |
Prof. CHAIR Sek Ying 車錫英 |
| 2009.088 | A Randomized Controlled Trial to Investigate the Impact of a Low Glycemic Index (GI) Diet on Body Mass Index and Obesity Related Cardiovascular and Hormonal Factors in Chinese Adolescents | Prof Kong Alice Pik Shan |
| 2019.332 | A randomized controlled trial to investigate the associations between a music program and neonatal health outcomes |
Ms. CHENG Shuk Man 鄭淑雯 |
| 2017.015 | A randomized controlled trial to examine the effectiveness of a genotype based lifestyle modification program on weight reduction in Chinese overweight and obese adults |
Dr. CHAN Ruth Suk Mei 陳淑薇 |
| 2003.127 | A Randomized Controlled Trial to Evaluate the Safety and Efficacy of the Medtronic AVE ABT-578 Eluting Driver Coronary Stent in De Novo Native Coronary Artery Lesions | Prof. Chan W.M. Wilson |
Page 226 of 262.